Recludix Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Recludix Pharma?

Recludix Pharma has 5 investors including Alexandria Venture Investments And Westlake Village BioPartners.

Q: When was the last funding round for Recludix Pharma?

Recludix Pharma closed its last funding round on obfuscated from a Undisclosed round.

Q: How much funding has Recludix Pharma raised to date?

Recludix Pharma has raised obfuscated.

Overview

Recludix Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Recludix Pharma

CB Rank

9856

Recludix pharma is a developing platform to treat cancer patients.

Founded

obfuscation

Private

Funding Round

San Diego, California, United States

51-100

recludixpharma.com

Biotechnology

Health Care

Funding Rounds

Funding Round

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Brian Hodous: Co-Founder, VP of Chemistry
Matthew Caldemeyer: Chief Business Officer

Details

Legal Name

Recludix Pharma, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Brian Hodous, Patrick Zarrinkar

About the Company

Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.

Phone Number

+1-858-258-5445

Contact Email

info@recludix.com

Diversity Spotlight

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

REX-8756

An oral, selective, and reversible small molecule inhibitor targeting STAT6 to inhibit Type 2 inflammatory disease pathways.

BTK SH2 Domain Inhibitor

A small molecule inhibitor targeting the SH2 domain of BTK to block BTK signaling in B cell and mast cell-driven inflammatory and immune diseases.

Research & Development

Recludix Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Recludix Pharma	4	obfuscated obfuscation	—	Funding Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Alexandria Venture Investments	—	Funding Round - Recludix Pharma	—
Alexandria Venture Investments	—	Funding Round - Recludix Pharma	—
Alexandria Venture Investments	—	Funding Round - Recludix Pharma	—
Alexandria Venture Investments	—	Funding Round - Recludix Pharma	—
Alexandria Venture Investments	—	Funding Round - Recludix Pharma	—